[Parkinsonism].
D000547:Amantadine / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications; D005799:Genes, Dominant; D006141:Guam; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease; D010301:Parkinson Disease, Postencephalitic / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000209:etiology; D026741:Physical Therapy Modalities; D013064:Speech Disorders / Q000209:etiology
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D007980:Levodopa; D000547:Amantadine
Parkinson-Syndrom.